Angany’s Unique Peanut Allergy Vaccine: Aiming to Overcome Peanut Allergy via Active Immunotherapy

Time: 9:15 am
day: Day One


  • Sharing allergen-bearing Ebioparticles™ mimicking viruses: why and how
  • Understanding the safety, efficacy and convenience of vaccinal approach: helping patients beyond the desensitization paradigm
  • Considering advantages and ethics of green biomanufacturing treating, curing, or preventing allergy?
  • The future: what Angany’s approaches to cancer immunotherapy and allergy immunotherapy have in common